, related to contain exon 1B, which reacts with two alternative splice acceptor sites within exon 1C; similar isoforms have been reported previously (Zhang et al., 2009 is indicated. F) The 5' FPN mRNA variants were analysed in mouse tissues by PCR using cDNA generated with random hexamers. The primer pairs used for PCR are indicated on the right and are depicted in (D); amplicon size is given in base pairs (bp). The 1C mRNA isoform bearing the IRE is very easily detected in all tissues, indicating relatively high expression. By contrast, the 1A-B1, 1A-B2, 1B1 and 1B2 isoforms are detected in a few tissues only. Moreover, more PCR cycles and longer image acquisition time were required to detect those isoforms, including in spleen, suggesting relatively low expression. This is in agreement with a previous report for the 1B1 and 1B2 isoforms (Zhang et al., 2009 These results suggest that reduced production of RNS ( Figure 3D ) is not the main mechanism underlying the antimicrobial deficit of Irp LyzCre(+) . Data are presented as averages ± SEM. The sample size (n) is indicated. TNFA and IL6, respectively, limit bacterial growth in both Cre and noCre BMDMs, and have an additive effect when added together. Unlike LCN2 (see Fig. 4C ), those cytokines fail to revert the antimicrobial deficit of Irp LyzCre(+) cells. Hence, insufficient LCN2 production appears to play a dominant role in the antimicrobial deficit of IRP-deficient macrophages, at least ex vivo. The sample size (n) is indicated. p:
Student's t-test (***: p<0.001). 
Blood iron parameters.
Red blood cell profiles and hemoglobin content were determined using the ABC Vet apparatus (ABX Diagnostics, Montpellier, France). Plasma iron and unbound iron binding capacity (UIBC) were assayed using the Iron SFBC and Iron UIBC kits (Biolabo, Maizy, France) and plasma ferritin concentration was determined using an Olympus 400 analyzer as described (Galy et al., 2013) .
Total non-heme iron levels. Liver and spleen tissues samples were dried and their non-heme iron content was measured using the bathophenanthroline method as described (Galy et al, 2005) . To determine cellular iron levels, BMDMs were lysed in 50 mM NaOH and the iron content was measured using the ferrozine chromophore as described (Riemer et al., 2004) . The results were calibrated to the protein content as determined with the Dc protein assay (Biorad, Munich, Germany).
RNA analysis. Total RNA extraction, reverse transcription (RT), and quantitative real-time PCR (qPCR)
were performed as described previously (Galy et al., 2013) . The primers used for qPCR are listed below.
Protein analysis. Tissue and cell lysates were prepared as described previously (Ferring-Appel et al., 2009) . Immunoblotting was performed using the antibodies listed below. Cytokine and NO assays. Specific ELISA kits were used to determine the concentration of TNFA, IL6, IL1β, IL12, IL10 (BD Biosciences, Heidelberg, Germany) and LCN2 (R&D Systems GmbH) in cell culture supernatants. Determination of nitrite, an oxidation product of NO, was carried out using the Griess reagent (Merck Millipore, Darmstadt, Germany).
Determination of reactive oxygen species (ROS) production. BMDMS from Irp LyzCre(+) versus Irp
LyzCre (-) mice were seeded onto 6-well plates and infected with S.Tm at a MOI of 20. 4 hours after infection, ROS were detected using the fluorigenic CellROX® Deep Red Reagent (Life technologies GmbH, Darmstadt, Germany) together with a Gallios™ TM flow cytometer (Beckman Coulter, Vienna, Austria); dead cells were excluded from the analysis after staining with the SYTOX® Dead Cell Stain (Life technologies GmbH).
Macrophage treatment with TNFA and/or IL6. Macrophages were infected with S.Tm at a MOI of 10 in the presence of IL6 (10 ng/ml, R&D Systems GmbH) and/or TNFA (10 ng/ml, R&D Systems GmbH) in the culture medium and intracellular bacterial multiplication was determined as described previously (Nairz et al., 2013) .
hmp mutant bacterial strain. The flavohemoglobin S.Tm mutant strain is an isogenic derivative of the S.
Tm wild-type strain ATCC 14028s. The strain was constructed and grown as described (Bang et al., 2006) .
Bacterial load determination in liver and spleen. The bacterial load was determined by plating serial dilutions of organ homogenates on LB agar (Sigma-Aldrich) under sterile conditions and the number of bacteria was calculated per gram of tissue as previously described (Nairz et al., 2013).
5'RACE. RACE was performed using total RNA from mouse spleen and the FirstChoice® RLM-RACE kit (Life technologies GmbH) following the instructions of the manufacturer. The PCR products obtained were subcloned into the pCR4®-TOPO TA cloning vector (Life technologies GmbH) for DNA sequencing. See below the sequence of FPN mRNA primers used for RACE.
Antibodies used for immunoblotting
Mouse monoclonal anti beta-ACTIN (clone AC15, Sigma-Aldrich) used 1/5000 in TBST (10 mM Tris pH8.0, 150 mM NaCl, 0.2% Tween20) + 5% dry milk.
Rabbit polyclonal anti-FPN/SLC40A1 (MTP11-A, Acris Antibodies GmbH, Herford, Germany), used 1 µg/ml in TBST + 5% dry milk.
Goat polyclonal anti-Ferritin L (sc-14420, Santa Cruz Biotechnology, Heidelberg, Germany), used 1/500 in TBST + 5% dry milk.
Goat polyclonal anti-Ferritin H (sc-14416, Santa Cruz Biotechnology), used 1/200 in TBST + 5% dry milk.
Mouse monoclonal anti-TFRC (clone H68.4, Life technologies GmbH), used 1/1000 in TBST + 5% dry milk.
Self-made rabbit polyclonal antibodies against IRP1 versus IRP2 (Galy, 2005b) , used 1/500 in TBST + 5% dry milk.
Tissue immunostaining
Tissue sections (10 µm) were prepared on cryostat (model CM3050; Leica Microsystems, Wetzlar, Germany) and fixed in methanol or in acetone, respectively, for detection of FPN and ferritin. Proteins of interest were detected using the following primary antibodies: rabbit polyclonal anti-ferritin L (F6136, Sigma, used 1/250), self-made rabbit polyclonal antibody against FPN (Galy, 2005b, used 1/250) (Schindelin et al., 2012) . 4-r 5'-ACGGACACATTCTGAACCACCAG-3' (reverse primer in exon 4)
